These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16142366)

  • 21. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
    Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
    Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays.
    Kumar JK; Holmgren S; Levedahl KH; Höglund M; Venge P; Eriksson S
    Biotechniques; 2020 Jun; 68(6):334-341. PubMed ID: 32336110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum detection of thymidine kinase 1 as a means of early detection of lung cancer.
    Alegre MM; Weyant MJ; Bennett DT; Yu JA; Ramsden MK; Elnaggar A; Robison RA; O'Neill KL
    Anticancer Res; 2014 May; 34(5):2145-51. PubMed ID: 24778016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
    von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
    J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Concentration of Thymidine Kinase 1 (TK1) as a Tumor Marker in Soft Tissue Sarcomas.
    Jaamaa S; Nevala R; Jagarlamudi K; Tukiainen E; Blomqvist C; Sampo M
    Anticancer Res; 2022 Mar; 42(3):1509-1515. PubMed ID: 35220246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Applicability of the Proliferation Marker Thymidine Kinase 1 in Head and Neck Cancer Patients.
    Meirovitz A; Gross M; Leibovici V; Sheva K; Popovzer A; Barak V
    Anticancer Res; 2021 Feb; 41(2):1083-1087. PubMed ID: 33517319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitive nonradiometric method for determining thymidine kinase 1 activity.
    Ohrvik A; Lindh M; Einarsson R; Grassi J; Eriksson S
    Clin Chem; 2004 Sep; 50(9):1597-606. PubMed ID: 15247154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum TK1 is a more reliable marker than CEA and AFP for cancer screening in a study of 56,286 people.
    Wang Y; Jiang X; Dong S; Shen J; Yu H; Zhou J; Li J; Ma H; He E; Skog S
    Cancer Biomark; 2016 Mar; 16(4):529-36. PubMed ID: 27002755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy.
    Nisman B; Yutkin V; Nechushtan H; Gofrit ON; Peretz T; Gronowitz S; Pode D
    Urology; 2010 Aug; 76(2):513.e1-6. PubMed ID: 20573390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aptamer-Based Sandwich Assay for Measurement of Thymidine Kinase 1 in Serum of Cancerous Patients.
    Nazari M; Gargari SLM; Sahebghadam Lotfi A; Rassaee MJ; Taheri RA
    Biochemistry; 2019 May; 58(18):2373-2383. PubMed ID: 30900869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes.
    Wang Z; Zhang W; Huo B; Dong L; Zhang J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial.
    Bjöhle J; Bergqvist J; Gronowitz JS; Johansson H; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Söderberg M; Sundquist M; Walz TM; Fernö M; Bergh J; Hatschek T
    Breast Cancer Res Treat; 2013 Jun; 139(3):751-8. PubMed ID: 23736998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum thymidine kinase activity in clinically healthy and diseased cats: a potential biomarker for lymphoma.
    Taylor SS; Dodkin S; Papasouliotis K; Evans H; Graham PA; Belshaw Z; Westberg S; von Euler HP
    J Feline Med Surg; 2013 Feb; 15(2):142-7. PubMed ID: 23076596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research on application value of combined detection of serum CA125, HE4 and TK1 in the diagnosis of ovarian cancer.
    Xi QP; Pu DH; Lu WN
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4536-4541. PubMed ID: 29131263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevation of serum thymidine kinase 1 in a bacterial infection: canine pyometra.
    Sharif H; Hagman R; Wang L; Eriksson S
    Theriogenology; 2013 Jan; 79(1):17-23. PubMed ID: 23102844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
    Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
    Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum thymidine kinase 1 predicts risk of pre/early cancerous progression.
    Huang S; Lin J; Guo N; Zhang M; Yun X; Liu S; Zhou J; He E; Skog S
    Asian Pac J Cancer Prev; 2011; 12(2):497-505. PubMed ID: 21545220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study: immunohistochemical detection of cytosolic thymidine kinase and proliferating cell nuclear antigen in breast cancer.
    Mao Y; Wu J; Wang N; He L; Wu C; He Q; Skog S
    Cancer Invest; 2002; 20(7-8):922-31. PubMed ID: 12449723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma.
    Wu BJ; Li WP; Qian C; Ding W; Zhou ZW; Jiang H
    Tumour Biol; 2013 Apr; 34(2):643-8. PubMed ID: 23179401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.